A small biotechnology company focused on genomic research and the development of biologics and related laboratory services. The business has historically operated as an early‑stage research and development platform, with activities tied to molecular biology and biotechnology applications. Investors ...
1 member of Congress has disclosed 1 trade in Incogen Corporation (INCOG), a Healthcare company. The buy/sell breakdown shows 1 purchase versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2015-08-25 | Kurt Schrader | buy | $1K – $15K |